Pursuing IRF4 as a therapeutic opportunity for lymphoid malignancies
Researchers
- Associate Professor Anselm Enders (Primary Investigator)
- Associate Professor Marco Casarotto (Secondary Investigator)
Grant status
ActiveGrant start date
01/01/2022Grant funding
- 2022: $388,671 from National Health and Medical Research Council (NHMRC)
- 2023: $373,961 from National Health and Medical Research Council (NHMRC)
- 2024: $416,652 from National Health and Medical Research Council (NHMRC)
- 2025: $254,947 from National Health and Medical Research Council (NHMRC)
